Your healthcare provider may decide to proceed with cautionor suggest an alternativeif you have: A history of pancreatitis , as the medication can increase the risk of recurrence
Participants were instructed to inject subcutaneously in the abdomen, thigh, or upper arm, rotating injection sites to minimize injection site reactions
Mild nausea, appetite suppression, and gastrointestinal adjustments are common initially and typically resolve as your body adapts
16 weeks (titration phase) 2-3 x 10 mg vials 1 mg 2 mg 4 mg 6 mg 9 mg across 16 weeks
The cornerstone of management involves both pharmacological strategies and practical lifestyle modifications that work synergistically to minimise gastrointestinal disturbance
If you want the cliff notes version, here it is: The GLP-1 agonists reduce blood sugar levels, slow digestion and significantly reduce appetite, making you feel fuller longer and eat less